Rothschild & Co Redburn analyst Simon Baker upgraded Novo Nordisk (NVO) to Buy from Neutral with a DKK 440 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk announced results from INFORM survey on semaglutide
- Novo Nordisk Stock (NVO) Rises After Triple-Dose Trial Hits 19% Weight Loss
- Novo looks to broaden options, stay competitive in weight-loss space, FT says
- Mixed options sentiment in Novo Nordisk with shares up 1.15%
- Microsoft, OpenAI sign MOU for next phase of partnership: Morning Buzz